Literature DB >> 21661735

Dynamic metabolic transformation in tumor invasion and metastasis in mice with LM-8 osteosarcoma cell transplantation.

Yingqi Hua1, Yunping Qiu, Aihua Zhao, Xiaoyan Wang, Tianlu Chen, Zhiyu Zhang, Yi Chi, Quan Li, Wei Sun, Guodong Li, Zhengdong Cai, Zhanxiang Zhou, Wei Jia.   

Abstract

While extensive evidence indicates that tumor cells shift their global metabolic programs, the molecular details of the metabolic transformation in tumor invasion, progression, and metastasis remain largely unknown. Characterization of the time-dependent metabolic shift during the tumor invasion, development, and metastasis will describe an important aspect of tumor phenotypes and potentially allow us to design therapies that inhibit tumor cell movement. In this study, a metabonomic study was performed to characterize the global metabolic changes during the process of tumor invasion and metastasis to lung in a mouse model with subcutaneous transplantation of murine osteosarcoma cell line (LM8). The serum metabolic profiling revealed that many key metabolites in glycolysis and tricarboxylic acid (TCA) cycle, as well as most of the amino acids were elevated at rapidly growing stage of tumor, presumably resulting from a high energy demand and turnover of anabolic metabolism during the tumor cell proliferation. Serum levels of succinic acid and proline significantly increased (with fold change FC = 10.75 and 4.43, relative to controls) among all the metabolites in the third week. The serum metabolic profile of lung metastasis at week 4 was different from that at week 3, in that most of previously increased serum metabolites were found decreased, except for cholesterol and several free fatty acids, suggesting lowered carbohydrate and amino acids metabolism, but an elevated lipid metabolism associated with tumor metastasis.

Entities:  

Mesh:

Year:  2011        PMID: 21661735     DOI: 10.1021/pr200147g

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  23 in total

Review 1.  Cell metabolomics.

Authors:  Aihua Zhang; Hui Sun; Hongying Xu; Shi Qiu; Xijun Wang
Journal:  OMICS       Date:  2013-08-29

Review 2.  The Heterogeneity of Lipid Metabolism in Cancer.

Authors:  Joshua K Park; Nathan J Coffey; Aaron Limoges; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 3.  Application of metabolomics in sarcoma: From biomarkers to therapeutic targets.

Authors:  Li Min; Edwin Choy; Chongqi Tu; Francis Hornicek; Zhenfeng Duan
Journal:  Crit Rev Oncol Hematol       Date:  2017-05-13       Impact factor: 6.312

Review 4.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

5.  Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo.

Authors:  Joseph L Sottnik; Janet C Lori; Barbara J Rose; Douglas H Thamm
Journal:  Clin Exp Metastasis       Date:  2011-08-14       Impact factor: 5.150

6.  Metabonomics identifies serum metabolite markers of colorectal cancer.

Authors:  Binbin Tan; Yunping Qiu; Xia Zou; Tianlu Chen; Guoxiang Xie; Yu Cheng; Taotao Dong; Linjing Zhao; Bo Feng; Xiaofang Hu; Lisa X Xu; Aihua Zhao; Menghui Zhang; Guoxiang Cai; Sanjun Cai; Zhanxiang Zhou; Minhua Zheng; Yan Zhang; Wei Jia
Journal:  J Proteome Res       Date:  2013-05-29       Impact factor: 4.466

7.  Metabolic Intersection of Cancer and Cardiovascular Diseases: Opportunities for Cancer Therapy.

Authors:  Giang Hoang; Kiet Nguyen; Anne Le
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  The Heterogeneity of Lipid Metabolism in Cancer.

Authors:  Joshua K Park; Nathan J Coffey; Aaron Limoges; Anne Le
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Pyruvate Carboxylase Is Up-Regulated in Breast Cancer and Essential to Support Growth and Invasion of MDA-MB-231 Cells.

Authors:  Phatchariya Phannasil; Chanitra Thuwajit; Malee Warnnissorn; John C Wallace; Michael J MacDonald; Sarawut Jitrapakdee
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

10.  Hybrid liposomes inhibit tumor growth and lung metastasis of murine osteosarcoma cells.

Authors:  Hideki Kitajima; Yuji Komizu; Hideaki Ichihara; Koichi Goto; Ryuichi Ueoka
Journal:  Cancer Med       Date:  2013-03-22       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.